Biolaser ApS: Financial statements 2017
CVR: 21333271
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Biolaser ApS (CVR 21333271) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 118,584 and a net result of DKK 91,592 compared with DKK 355,656 the year before. That is a decrease of 74% compared with the year before. Equity in the 2017 report amounted to DKK 648,903. The solvency ratio was 61.5%.
- Gross Profit
- DKK 118,584
- Profit/Loss
- DKK 91,592
- Equity
- DKK 648,903
- Total Assets
- DKK 1,054,801
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 119 t. | 92 t. | 649 t. | - |
| 2016 | - | 456 t. | 356 t. | 557 t. | - |
| 2015 | - | 207 t. | 66 t. | 202 t. | - |
| 2014 | - | 11 t. | -8 t. | 136 t. | - |
| 2013 | - | 80 t. | 15 t. | 144 t. | - |
Keep an eye on Biolaser ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Biolaser ApS has published its annual report for 2016. Gross profit came to DKK 456,055, and the net result was DKK 355,656.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.